Get them answered by the team at Procter & Gamble.
Background
Consumers are increasingly seeking more environmentally responsible product choices.
We are looking for unique solutions to directly transform fatty acid methyl esters (or triglycerides) into a key raw material, linear alpha olefins, for later conversion to surfactants that can be utilized in consumer products. The solution could be chemical or non-chemical (e.g. biotransformation), processes, technologies, materials (e.g. catalysts) and/or services.
If you have a solution and want to partner with us, please submit a summary of your solution, approach and/or technologies. Please indicate how you would propose pilot testing your solution. We look forward to partnering with you. All ideas and submissions will be fully reviewed.
What we're looking for
Technologies that are either demonstrated at lab scale, demonstrated at pilot (scalable), or “off the shelf” or “near-ready”. We would prefer an “off the shelf” or “near-ready” solution.
We would also consider emerging technology(ies) as a possible co-development. A solution that is scalable.
Only non-confidential information is acceptable.
Solutions of interest include:
Direct chemical conversion of fatty acid methyl esters to linear alpha olefins
Direct biogenic conversion of fatty acid methyl esters to linear alpha olefins
Other 1-step solutions for converting fatty acid methyl esters to linear alpha olefins
Our must-have requirements are:
Direct (1-step) conversion
Starting compounds must be fatty acid methyl esters or triglycerides
Resultant product are linear alpha-olefins with unsaturation in the 1-position. If a mixture of isomers, the mixture must be >90% with unsaturation in the 1-position.
What's out of scope:
We are not interested in solutions to internal olefins (whether pure or mixtures).
We are not interested in solutions starting from fatty alcohols.
We are not interested in olefins with fewer than eight carbons and olefins with greater than sixteen carbons.
Acceptable technology readiness levels (TRL):
Levels 4-9
What we can offer you
Eligible partnership models:
Co-development
Supply/purchase
Licensing
Material transfer
Sponsored research
Benefits:
Sponsored Research
Depending on relevancy and scope of proposed research, we will consider sponsored research funding within the norms of typical industry sponsored chemical research.
Expertise
Industrial expertise in chemistry & chemical engineering.
Tools and Technologies
We have broad R&D capability in analytical characterization.
Facilities and Services
Lab and pilot scale facilities - including catalytic processes.
Compounds and Reagents
We have access to oleochemicals such as methyl esters and triglycerides that can be supplied as needed for starting materials.
Who we are
At P&G, innovation is what we do best. We love finding solutions to problems. With the heart of a start-up and the resources of a global corporation, we are always looking for ways to reinvent every aspect of our business. As we innovate, we find inspiration in people - their needs, values, desires, and passions. The people of P&G R&D know that collaboration is key to unlocking visionary thinking. Our experts seamlessly work together with our external partners in the pursuit of the new, the next, the impossible.
Work already done or in progress is acceptable, technical rational and results will be reviewed. However, proposals for research put forward with technical rationale will be considered as well.
Pete Ellingson, Director / Open Innovation, Procter & Gamble
August 12, 2024
Is this response helpful?
0
0
Q.
Would a biogenic application be considered if its technically two-three steps but all in the same "pot" so to speak? Or are you only looking for applications that are one reaction?
Fewer steps are preferred. However, single step or multiple steps in one reactor or series of reactors will be considered. Conversion, yield, and selectivity are all important metrics for the desired transformation.